February 20, 2023Open Access

Safely Prescribing Nirmatrelvir and Ritonavir—Avoiding Drug-Drug Interactions

Key Points

Key points are not available for this paper at this time.

Abstract

This Teachable Moment discusses drug-drug interactions with nirmatrelvir and ritonavir (Paxlovid) treatment for COVID-19 and considerations when prescribing.

KI fragen

Bookmark

View Full Paper

Cite This Study

Culas et al. (Mon,) studied this question.

synapsesocial.com/papers/69d8aa13183921ebcaae33f4 https://doi.org/https://doi.org/10.1001/jamainternmed.2022.6834

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1Risks Associated With Statin Therapy2006 · 483 citations
2Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-192022 · 2,185 citations
3Drug Prescribing: Drug-Drug Interactions.2021 · 15 citations
4Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation2013 · 4,101 citations

KI fragen

Bookmark

View Full Paper